Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drugs in Japan - PubMed (original) (raw)
Tomoki Inaba, Motowo Mizuno, Hiroyuki Okada, Kenji Kuwaki, Toshiaki Kuzume, Hitomi Yokota, Yasuyo Fukuda, Kou Takeda, Hiroshi Nagano, Masaki Wato, Kozo Kawai
Affiliations
- PMID: 18323869
- DOI: 10.18926/AMO/30992
Free article
Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drugs in Japan
Shigenao Ishikawa et al. Acta Med Okayama. 2008 Feb.
Free article
Abstract
Upper gastrointestinal bleeding is a major adverse event of non-steroidal anti-inflammatory drugs (NSAIDs), and co-administration of proton pump inhibitors and H2 receptor antagonists has been established as a means of preventing such an effect. However, the incidence of bleeding associated with NSAID-induced ulcers under conditions where such strong anti-acid agents are used for prevention has yet to be clarified. We aimed to determine the annual incidence of serious upper gastrointestinal ulcer bleeding among Japanese patients in whom NSAIDs were used in our hospital. Before commencing the study, we recommended to all the physicians in our hospital the best method for caring for NSAID users, focusing on the concomitant use of proton pump inhibitors or H2 receptor antagonists. We conducted a cohort study involving 17,270 patients for whom NSAIDs had been newly prescribed. Bleeding from gastric ulcers was observed in 8 of the 17,270 patients using NSAIDs (0.05%). The pooled incidence rate for bleeding was calculated as 2.65 (95% confidence interval, 2.56-2.74) and 1.29 (1.27-1.31) per 1,000 patient years for low-dose aspirin and non-aspirin NSAID users, respectively. None of the bleeding ulcer patients required blood transfusion or were in serious condition. In conclusion, gastric ulcer bleeding occurred in low-dose aspirin or non-aspirin NSAID users, but its incidence was low and outcomes were not serious when adequate preventive measures were taken.
Similar articles
- Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
Iwamoto J, Saito Y, Honda A, Matsuzaki Y. Iwamoto J, et al. World J Gastroenterol. 2013 Mar 21;19(11):1673-82. doi: 10.3748/wjg.v19.i11.1673. World J Gastroenterol. 2013. PMID: 23555156 Free PMC article. Review. - A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs.
Nakashima S, Arai S, Mizuno Y, Yoshino K, Ando S, Nakamura Y, Sugawara K, Koike M, Saito E, Naito M, Nakao M, Ito H, Hamaoka K, Rai F, Asakura Y, Akamatu M, Fujimori K, Inao M, Imai Y, Ota S, Fujiwara K, Shiibashi M. Nakashima S, et al. Aliment Pharmacol Ther. 2005 Jun;21 Suppl 2:60-6. doi: 10.1111/j.1365-2036.2005.02476.x. Aliment Pharmacol Ther. 2005. PMID: 15943849 - Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial.
Chan FKL, Ching JYL, Tse YK, Lam K, Wong GLH, Ng SC, Lee V, Au KWL, Cheong PK, Suen BY, Chan H, Kee KM, Lo A, Wong VWS, Wu JCY, Kyaw MH. Chan FKL, et al. Lancet. 2017 Jun 17;389(10087):2375-2382. doi: 10.1016/S0140-6736(17)30981-9. Epub 2017 Apr 11. Lancet. 2017. PMID: 28410791 Clinical Trial. - The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.
Pilotto A, Franceschi M, Leandro G, Paris F, Niro V, Longo MG, D'Ambrosio LP, Andriulli A, Di Mario F. Pilotto A, et al. Aging Clin Exp Res. 2003 Dec;15(6):494-9. doi: 10.1007/BF03327372. Aging Clin Exp Res. 2003. PMID: 14959953
Cited by
- Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
Iwamoto J, Saito Y, Honda A, Matsuzaki Y. Iwamoto J, et al. World J Gastroenterol. 2013 Mar 21;19(11):1673-82. doi: 10.3748/wjg.v19.i11.1673. World J Gastroenterol. 2013. PMID: 23555156 Free PMC article. Review. - Gastroprotective Effects of Grape Seed Proanthocyanidin Extracts against Nonsteroid Anti-Inflammatory Drug-Induced Gastric Injury in Rats.
Kim TH, Jeon EJ, Cheung DY, Kim CW, Kim SS, Park SH, Han SW, Kim MJ, Lee YS, Cho ML, Chang JH, Min JK, Kim JI. Kim TH, et al. Gut Liver. 2013 May;7(3):282-9. doi: 10.5009/gnl.2013.7.3.282. Epub 2013 Apr 9. Gut Liver. 2013. PMID: 23710308 Free PMC article. - Frequency-risk and duration-risk relationships between aspirin use and gastric cancer: a systematic review and meta-analysis.
Ye X, Fu J, Yang Y, Gao Y, Liu L, Chen S. Ye X, et al. PLoS One. 2013 Jul 30;8(7):e71522. doi: 10.1371/journal.pone.0071522. Print 2013. PLoS One. 2013. PMID: 23936269 Free PMC article. Review. - Aspirin use and the risk of gastric cancer: a meta-analysis.
Yang P, Zhou Y, Chen B, Wan HW, Jia GQ, Bai HL, Wu XT. Yang P, et al. Dig Dis Sci. 2010 Jun;55(6):1533-9. doi: 10.1007/s10620-009-0915-0. Epub 2009 Aug 12. Dig Dis Sci. 2010. PMID: 19672710 Review. - Time trends in incidence of peptic ulcer bleeding and associated risk factors in Norway 1985-2008.
Bakkevold KE. Bakkevold KE. Clin Exp Gastroenterol. 2010;3:71-7. doi: 10.2147/ceg.s10921. Epub 2010 Jun 29. Clin Exp Gastroenterol. 2010. PMID: 21694849 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources